Literature DB >> 8708345

An exploratory study of the relationship between alternative therapies, functional status, and symptom severity among people with multiple sclerosis.

J Fawcett, J S Sidney, K Riley-Lawless, M J Hanson.   

Abstract

Roy's Adaptation Model guided an exploratory study of the association of alternative therapies with functional status and symptoms in people with multiple sclerosis (MS). Data were collected from 16 volunteers by a telephone-administered interview schedule and a mailed questionnaire. All 16 respondents reported seeking traditional medical treatment and at least 1 alternative therapy (mode = 3, range = 1-9). The correlation between the number of alternative therapies and functional status was -.42; the greater the number of therapies used by the respondents, the lower their functional status. Qualitative data analysis revealed that functional status was enhanced by beneficial effects of specific alternative therapies, pacing oneself, changing the perception of self, and focusing on spiritual aspects of self. Self-reported MS symptoms were less severe following use of alternative therapies (p < .0005). Study of the differential effects of single and combined alternative therapies on functional status and symptom severity for large samples of people with MS is recommended.

Entities:  

Mesh:

Year:  1996        PMID: 8708345     DOI: 10.1177/089801019601400204

Source DB:  PubMed          Journal:  J Holist Nurs        ISSN: 0898-0101


  2 in total

1.  Complementary and Alternative Medicine Usage by Multiple Sclerosis Patients: Results from a Prospective Clinical Study.

Authors:  Soohyun Kim; Lawrence Chang; Bianca Weinstock-Guttman; Sirin Gandhi; Dejan Jakimovski; Ellen Carl; Robert Zivadinov; Murali Ramanathan
Journal:  J Altern Complement Med       Date:  2018-03-02       Impact factor: 2.579

2.  Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey.

Authors:  Joshua M Bauml; Sagar Chokshi; Marilyn M Schapira; Eun-Ok Im; Susan Q Li; Corey J Langer; Said A Ibrahim; Jun J Mao
Journal:  Cancer       Date:  2015-05-26       Impact factor: 6.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.